Prof. Fabian Kiessling, RWTH Aachen, Institute of Experimental Molecular Imaging
Fabian Kiessling presents some aspects of their research on optical tomography. For a detailed biodistribution analysis, PET and SPECT are usually preferred as they are more accurate and quantitative, so the question is, can optical imaging become a complementary tool for pre-clinical biodistribution analysis?
The talk took place at the EMIM 2022.
You may also like
This webinar describes Miltenyi Biotech’s approach establishing multimodal optical imaging of CAR T cell therapies, using the MILabs optical imaging micro CT system.
The Institute for Experimental Molecular Imaging’s (RWTH Aachen) research team uses MILabs Optical imaging system, intravital microscopy, and immunohistochemistry to investigate cancer nanomedicine delivery and uptake in vivo.
This webinar covers some recent groundbreaking studies conducted by the Cornelissen group in Oxford. Several recent papers will be presented including ‘Early detection in a mouse model of pancreatic cancer by imaging DNA damage response signaling’, ‘Dual-isotope antibody imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours’, and ‘Imaging DNA Damage Repair in vivo Following 177Lu-DOTATATE Therapy’.
